All Stories

  1. Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma

    Article • Cancer Letters, February 2026, Elsevier

    Dr. Fatima Baltazar

  2. Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer

    Article • Cell Biology and Toxicology, January 2026, Springer Science + Business Media

    Dr. Fatima Baltazar

  3. Rational design of anticancer multidrug nanosystems and their adaptation for glioblastoma treatment

    Article • Drug Delivery and Translational Research, December 2025, Springer Science + Business Media

    Dr. Fatima Baltazar

  4. Functional and Mechanistic Insights of 3-Hydroxybutyrate (3-OBA) in Bladder Cancer

    Article • Molecules, December 2025, MDPI AG

    Dr. Fatima Baltazar

  5. Metabolism-targeted therapy in NSCLC – A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24)

    Article • Biomedicine & Pharmacotherapy, September 2025, Elsevier

    Maria Manuela Gaspar, Dr. Fatima Baltazar

  6. Multimodal nanoparticles co-delivering bevacizumab and dichloroacetate for dual targeting of neoangiogenesis and hyperglycolysis in glioblastoma treatment

    Article • Journal of Controlled Release, August 2025, Elsevier

    Dr. Fatima Baltazar

  7. 3-Bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by a pro-oxidant mechanism

    Article • Free Radical Biology and Medicine, July 2025, Elsevier

    Dr. Fatima Baltazar

  8. Exposure to potentially harmful excipients in neonates admitted to intensive care units using compounded medicines

    Article • European Journal of Hospital Pharmacy, April 2025, BMJ

    Dr. Fatima Baltazar

  9. Raman spectroscopy for classification of neoplastic and non-neoplastic CAM colon tumors

    Article • Heliyon, September 2024, Elsevier

    Dr. Fatima Baltazar

  10. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect

    Article • Cancers, April 2024, MDPI AG

    Dr. Fatima Baltazar

  11. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia

    Article • Pharmaceutics, March 2024, MDPI AG

    Dr. Fatima Baltazar

  12. Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer

    Article • Pharmaceutics, November 2023, MDPI AG

    Dr. Fatima Baltazar

  13. Optimization of iron-ZIF-8 catalysts for degradation of tartrazine in water by Fenton-like reaction

    Article • Chemosphere, October 2023, Elsevier

    Professor Isabel Correia Neves, Dr. Fatima Baltazar, Professor M. Fernando R Pereira

  14. Sustainable fluorescent dye-faujasite zeolite systems as tools for cancer bioimaging

    Article • Chemical Engineering Journal, October 2023, Elsevier

    Dr. Fatima Baltazar

  15. Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell

    Article • Cancers, July 2023, MDPI AG

    Dr. Fatima Baltazar

  16. Phenolic Compounds Contribution to Portuguese Propolis Anti-Melanoma Activity

    Article • Molecules, March 2023, MDPI AG

    Cristina Aguiar, Dr. Fatima Baltazar

  17. Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Dr. Fatima Baltazar

  18. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy

    Article • Cancers, February 2023, MDPI AG

    Dr. Fatima Baltazar

  19. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study

    Article • Journal of Applied Oral Science, January 2023, FapUNIFESP (SciELO)

    Dr. Fatima Baltazar

  20. Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Maria João Sousa, Dr. Fatima Baltazar

  21. 3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Dr. Fatima Baltazar

  22. Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy

    Article • Pharmaceutics, November 2022, MDPI AG

    Dr. Fatima Baltazar

  23. Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells

    Article • Molecules, June 2022, MDPI AG

    Cristina Aguiar, Dr. Fatima Baltazar

  24. Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis

    Article • Molecules, May 2022, MDPI AG

    Cristina Aguiar, Dr. Fatima Baltazar

  25. In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome–DNA Complexes

    Article • Pharmaceutics, May 2022, MDPI AG

    Dr. Fatima Baltazar

  26. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics

    Article • Pharmaceutics, February 2022, MDPI AG

    Dr. Fatima Baltazar

  27. Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer

    Article • Food & Function, January 2022, Royal Society of Chemistry

    Dr. Fatima Baltazar

  28. In Vivo Anticancer Activity of AZD3965: A Systematic Review

    Article • Molecules, December 2021, MDPI AG

    Dr. Fatima Baltazar

  29. MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma

    Article • Cancers, July 2021, MDPI AG

    Dr. Fatima Baltazar

  30. Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186

    Article • Cancers, April 2021, MDPI AG

    Dr. Fatima Baltazar

  31. Nestin Expression Is Associated with Relapses in Head and Neck Lesions

    Article • Diagnostics, March 2021, MDPI AG

    Dr. Fatima Baltazar

  32. Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells

    Article • Pharmaceutics, February 2021, MDPI AG

    Dr. Fatima Baltazar

  33. Angiogenesis and Chromene-based Antiangiogenic Therapeutic Agents

    Article • October 2020, Bentham Science Publishers

    Ana Cunha, Dr. Fatima Baltazar

  34. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route

    Article • Drug Delivery and Translational Research, July 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  35. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications

    Article • Current Medicinal Chemistry, July 2020, Bentham Science Publishers

    Dr. Fatima Baltazar, Sara Gomes

  36. The metabolic landscape of urological cancers: New therapeutic perspectives

    Article • Cancer Letters, May 2020, Elsevier

    Dr. Fatima Baltazar

  37. Microbes and Cancer: Friends or Faux?

    Article • International Journal of Molecular Sciences, April 2020, MDPI AG

    Dr. Fatima Baltazar

  38. IL-17A and IL-17F orchestrate macrophages to promote lung cancer

    Article • Cellular Oncology, March 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  39. Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Fatima Baltazar

  40. A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems

    Article • Drug Delivery and Translational Research, January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  41. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

    Article • Nature Reviews Urology, January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  42. Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

    Article • Physiological Reviews, January 2020, American Physiological Society

    Dr. Fatima Baltazar

  43. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect

    Article • January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  44. New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention

    Article • January 2020, Elsevier

    Dr. Fatima Baltazar

  45. 3D culture systems as models for solid tumors and cancer metabolism

    Article • January 2020, Elsevier

    Dr. Fatima Baltazar

  46. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo

    Article • Carbohydrate Polymers, November 2019, Elsevier

    Dr. Fatima Baltazar

  47. Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy

    Article • Pharmaceutics, September 2019, MDPI AG

    Dr. Fatima Baltazar

  48. Direct actions of adiponectin on changes in reproductive, metabolic, and anti-oxidative enzymes status in the testis of adult mice

    Article • General and Comparative Endocrinology, August 2019, Elsevier

    Dr. Fatima Baltazar

  49. Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display

    Article • Scientific Reports, March 2019, Springer Science + Business Media

    Dr. Fatima Baltazar

  50. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma

    Article • Cellular Oncology, February 2019, Springer Science + Business Media

    Dr. Fatima Baltazar

  51. Role of adiponectin as a modulator of testicular function during aging in mice

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, February 2019, Elsevier

    Dr. Fatima Baltazar

  52. Synthesis, characterization and in vitro validation of a magnetic zeolite nanocomposite with T2-MRI properties towards theranostic applications

    Article • Journal of Materials Chemistry B, January 2019, Royal Society of Chemistry

    Professor Isabel Correia Neves, Dr. Fatima Baltazar

  53. Photodynamic Therapy at Low-Light Fluence Rate: in vitro Assays on Colon Cancer Cells

    Article • IEEE Journal of Selected Topics in Quantum Electronics, January 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Fatima Baltazar

  54. Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment

    Article • European Journal of Medicinal Chemistry, September 2018, Elsevier

    Dr. Fatima Baltazar, Paula Ludovico

  55. Adenine Derivatives: Promising Candidates for Breast Cancer Treatment

    Article • European Journal of Organic Chemistry, July 2018, Wiley

    Dr. Fatima Baltazar

  56. Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy

    Article • Journal of Cellular and Molecular Medicine, May 2018, Wiley

    Dr. Fatima Baltazar

  57. The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr. Fatima Baltazar

  58. Internalization studies on zeolite nanoparticles using human cells

    Article • Journal of Materials Chemistry B, January 2018, Royal Society of Chemistry

    Professor Isabel Correia Neves, Dr. Fatima Baltazar

  59. Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells

    Article • Oncotarget, October 2017, Impact Journals, LLC

    Dr. Fatima Baltazar

  60. Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology

    Article • Journal of Translational Medicine, October 2017, Springer Science + Business Media

    Dr. Fatima Baltazar

  61. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2017, Elsevier

    Dr. Fatima Baltazar

  62. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk

    Article • Molecular Carcinogenesis, August 2017, Wiley

    Dr. Rui M Reis, Professor Fatima Baltazar, Dr. Fatima Baltazar

  63. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Dr. Fatima Baltazar

  64. Value of pH regulators in the diagnosis, prognosis and treatment of cancer

    Article • Seminars in Cancer Biology, April 2017, Elsevier

    Dr. Fatima Baltazar

  65. Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors

    Article • RSC Advances, January 2017, Royal Society of Chemistry

    Professor M. Fernando R Pereira, Professor Isabel Correia Neves, Dr. Fatima Baltazar

  66. HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors

    Article • Theranostics, January 2017, Ivyspring International Publisher

    Dr. Fatima Baltazar

  67. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications

    Article • Oncotarget, September 2016, Impact Journals, LLC

    Dr. Fatima Baltazar

  68. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation

    Article • Endocrine, August 2016, Springer Science + Business Media

    Tommaso Bizzarro, Professor Fernando Schmitt, Dr. Fatima Baltazar

  69. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis

    Article • BMC Cancer, July 2016, Springer Science + Business Media

    Dr. Fatima Baltazar

  70. The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

    Article • Journal of Bioenergetics and Biomembranes, July 2016, Springer Science + Business Media

    Dr. Fatima Baltazar

  71. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas

    Article • Oncotarget, June 2016, Impact Journals, LLC

    Dr. Fatima Baltazar

  72. Antitumor Properties of Honeybee Plant-Derived Products: Honey, Propolis and Pollen

    Article • June 2016, Bentham Science Publishers

    Professor Fatima Baltazar, Cristina Aguiar, Dr. Fatima Baltazar

  73. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors

    Article • Cell Cycle, May 2016, Taylor & Francis

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  74. Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas

    Article • Current Cancer Drug Targets, May 2016, Bentham Science Publishers

    Dr. Fatima Baltazar

  75. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4

    Article • Cell Cycle, May 2016, Taylor & Francis

    Dr. Fatima Baltazar

  76. Absence of microsatellite instability andBRAF(V600E) mutation in testicular germ cell tumors

    Article • Andrology, May 2016, Wiley

    Dr. Rui M Reis, Dr. Fatima Baltazar

  77. Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness

    Article • Cell Cycle, January 2016, Taylor & Francis

    Dr. Fatima Baltazar

  78. Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation

    Article • Phytotherapy Research, December 2015, Wiley

    Dr. Fatima Baltazar

  79. Targeting Metabolic Reprogramming as an Anti- Cancer Strategy: Aiming at Monocarboxylate Transporters

    Article • December 2015, Bentham Science Publishers

    Dr. Fatima Baltazar, Professor Fatima Baltazar

  80. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors

    Article • Oncotarget, November 2015, Impact Journals, LLC

    Dr. Fatima Baltazar

  81. Hotspot TERT promoter mutations are rare events in testicular germ cell tumors

    Article • Tumor Biology, November 2015, Springer Science + Business Media

    Paula Soares, Dr. Fatima Baltazar

  82. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas

    Article • BMC Cancer, November 2015, Springer Science + Business Media

    Dr. Fatima Baltazar

  83. Glucose addiction in cancer therapy: advances and drawbacks

    Article • Current Drug Metabolism, August 2015, Bentham Science Publishers

    Professor Fatima Baltazar, Dr. Fatima Baltazar

  84. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells

    Article • Cancer Letters, August 2015, Elsevier

    Dr. Fatima Baltazar

  85. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy

    Article • The Journal of Pathology, July 2015, Wiley

    Valdemar Máximo, Dr. Fatima Baltazar

  86. Abstract B24: Natural withanolides: A new group of anticancer drugs that selectively target the PI3K-mTOR pathway as novel potent therapeutics against colon cancers in vitro and in vivo

    Article • July 2015, American Association for Cancer Research (AACR)

    Dr. Fatima Baltazar

  87. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria

    Article • Cell Death and Disease, June 2015, Springer Science + Business Media

    Dr. Fatima Baltazar

  88. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

    Article • Oncotarget, April 2015, Impact Journals, LLC

    Dr. Fatima Baltazar

  89. The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH

    Article • Biochemical Journal, April 2015, Portland Press Ltd.

    Dr. Fatima Baltazar

  90. Brain Tumor Metabolism — Unraveling Its Role in Finding New Therapeutic Targets

    Article • March 2015, IntechOpen

    Dr. Fatima Baltazar

  91. Impact of an Educational Hands-on Project on the Antimicrobial, Antitumor and Anti-Inflammatory Properties of Plants on Portuguese Students’ Awareness, Knowledge, and Competences

    Article • International Journal of Environmental Research and Public Health, February 2015, MDPI AG

    Dr. Fatima Baltazar

  92. Micro- and Mesoporous Structures as Drug Delivery Carriers for Salicylic Acid

    Article • The Journal of Physical Chemistry C, February 2015, American Chemical Society (ACS)

    Professor M. Fernando R Pereira, Professor Isabel Correia Neves, Dr. Fatima Baltazar

  93. Localization of MCT 2 at peroxisomes is associated with malignant transformation in prostate cancer

    Article • Journal of Cellular and Molecular Medicine, January 2015, Wiley

    Dr. Fatima Baltazar

  94. In vitro and in vivo studies of temozolomide loading in zeolite structures as drug delivery systems for glioblastoma

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Isabel Correia Neves, Dr. Fatima Baltazar

  95. Urothelial bladder cancer progression: lessons learned from the bench

    Article • Journal of Cancer Metastasis and Treatment, January 2015, OAE Publishing

    Dr. Fatima Baltazar

  96. Evolving hallmarks in urothelial bladder cancer: unveiling potential biomarkers

    Article • Acta Urológica Portuguesa, January 2015, Associacao Portuguesa de Urologia

    Dr. Fatima Baltazar

  97. Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development

    Article • Evidence-based Complementary and Alternative Medicine, January 2015, Hindawi Publishing Corporation

    Dr. Fatima Baltazar, Cristina Aguiar

  98. Antitumoural and antiangiogenic activity of Portuguese propolis in in vitro and in vivo models

    Article • Journal of Functional Foods, November 2014, Elsevier

    Dr. Fatima Baltazar, Cristina Aguiar

  99. Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?

    Article • International Journal of Molecular Sciences, October 2014, MDPI AG

    Dr. Fatima Baltazar

  100. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix

    Article • BMC Cancer, October 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  101. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype

    Article • BMC Cancer, October 2014, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  102. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

    Article • Molecular Carcinogenesis, September 2014, Wiley

    Professor Fatima Baltazar, Dr. Fatima Baltazar

  103. T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness

    Article • Clinical Cancer Research, July 2014, American Association for Cancer Research (AACR)

    Dr. Fatima Baltazar

  104. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

    Article • BMC Cancer, May 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  105. Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization

    Article • Journal of Translational Medicine, January 2014, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  106. Characterization of monocarboxylate transporter activity in hepatocellular carcinoma

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Fatima Baltazar

  107. Gene Disruption Using Zinc Finger Nuclease Technology

    Article • January 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  108. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma

    Article • Colloids and Surfaces B Biointerfaces, December 2013, Elsevier

    Professor Isabel Correia Neves, Professor M. Fernando R Pereira, Dr. Fatima Baltazar

  109. Differential sensitivities to lactate transport inhibitors of breast cancer cell lines

    Article • October 2013, Bioscientifica

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  110. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma

    Article • Cell Cycle, August 2013, Taylor & Francis

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  111. Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro

    Article • BMC Complementary and Alternative Medicine, July 2013, Springer Science + Business Media

    Dr. Fatima Baltazar, Cristina Aguiar

  112. Assessing the Impact of a School Intervention to Promote Students’ Knowledge and Practices on Correct Antibiotic Use

    Article • International Journal of Environmental Research and Public Health, July 2013, MDPI AG

    Dr. Fatima Baltazar

  113. Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin

    Article • Journal of Bioenergetics and Biomembranes, June 2013, Springer Science + Business Media

    Dr. Fatima Baltazar

  114. Contribution of Monocarboxylate Transporters to the Aggressive Phenotype of Breast Cancer

    Article • Annals of Oncology, March 2013, Elsevier

    Dr. Fatima Baltazar

  115. NIR Triggered Upconversion Nanoparticle Based Drug Delivery Systems for Photodynamic Therapy

    Article • January 2013, Optical Society of America (OSA)

    Dr. Fatima Baltazar

  116. A Hospital Based Cohort Study of Colorectal Cancer Cases Treated at Braga Hospital, Northern Portugal

    Article • Journal of Gastrointestinal & Digestive System, January 2013, OMICS Publishing Group

    Dr. Fatima Baltazar

  117. The Monocarboxylate Transporter Inhibitor α-Cyano-4-Hydroxycinnamic Acid Disrupts Rat Lung Branching

    Article • Cellular Physiology and Biochemistry, January 2013, Karger Publishers

    Dr. Fatima Baltazar

  118. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets

    Article • Neuro-Oncology, December 2012, Oxford University Press (OUP)

    Dr. Fatima Baltazar

  119. Zeolite Structures Loading with an Anticancer Compound As Drug Delivery Systems

    Article • The Journal of Physical Chemistry C, December 2012, American Chemical Society (ACS)

    Professor Isabel Correia Neves, Dr. Fatima Baltazar

  120. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer

    Article • The Prostate, November 2012, Wiley

    Dr. Fatima Baltazar

  121. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma

    Article • Diagnostic Cytopathology, May 2012, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  122. Lactate-Induced IL-8 Pathway in Endothelial Cells--Letter

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  123. Role of monocarboxylate transporters in human cancers: state of the art

    Article • Journal of Bioenergetics and Biomembranes, February 2012, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  124. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate

    Article • Journal of Bioenergetics and Biomembranes, February 2012, Springer Science + Business Media

    Dr. Fatima Baltazar

  125. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)

    Article • Journal of Bioenergetics and Biomembranes, January 2012, Springer Science + Business Media

    Dr. Fatima Baltazar

  126. CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis

    Article • European Journal of Surgical Oncology, September 2011, Elsevier

    Dr. Fatima Baltazar

  127. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

    Article • BMC Cancer, July 2011, Springer Science + Business Media

    Dr. Fatima Baltazar

  128. Encapsulation of α-cyano-4-hydroxycinnamic acid into a NaY zeolite

    Article • Journal of Materials Science, June 2011, Springer Science + Business Media

    Professor Isabel Correia Neves, Dr. Fatima Baltazar

  129. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies

    Article • World Journal of Clinical Oncology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Fatima Baltazar

  130. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma

    Article • Histopathology, June 2010, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  131. The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment

    Article • Inflammation Research, March 2010, Springer Science + Business Media

    Dr. Fatima Baltazar

  132. Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44

    Article • Journal of Biomedicine and Biotechnology, January 2010, Hindawi Publishing Corporation

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  133. Portuguese students' knowledge of antibiotics: a cross-sectional study of secondary school and university students in Braga

    Article • BMC Public Health, September 2009, Springer Science + Business Media

    Dr. Fatima Baltazar

  134. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer

    Article • European Journal of Cancer, September 2009, Elsevier

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  135. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma

    Article • BMC Cancer, June 2009, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  136. Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma

    Article • International Journal of Gynecological Pathology, October 2008, Wolters Kluwer Health

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  137. 378 POSTER CD147 expression correlates with monocarboxylate transporters 1 and 4 in cervical carcinoma

    Article • European Journal of Cancer Supplements, October 2008, Elsevier

    Dr. Fatima Baltazar

  138. Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer

    Article • Investigational New Drugs, June 2008, Springer Science + Business Media

    Dr. Fatima Baltazar

  139. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis

    Article • Experimental and Toxicologic Pathology, April 2008, Elsevier

    Dr Jose Mauricio Mota, Professor Fernando Schmitt, Dr. Fatima Baltazar

  140. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas

    Article • Virchows Archiv, January 2008, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  141. A New Model of Laryngitis: Neuropeptide, Cyclooxygenase, and Cytokine Profile

    Article • The Laryngoscope, January 2008, Wiley

    Dr. Fatima Baltazar

  142. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers

    Article • Virchows Archiv, December 2007, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  143. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix

    Article • Gynecologic Oncology, October 2007, Elsevier

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  144. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats

    Article • Journal of Cancer Research and Clinical Oncology, July 2007, Springer Science + Business Media

    Professor Gerly Anne de Castro Brito, Professor Fernando Schmitt, Dr. Fatima Baltazar

  145. Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas

    Article • International Journal of Gynecological Pathology, July 2007, Wolters Kluwer Health

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  146. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma

    Article • Diagnostic Cytopathology, January 2007, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  147. Functional Purification of the Monocarboxylate Transporter of the Yeast Candida utilis

    Article • Biotechnology Letters, June 2006, Springer Science + Business Media

    Dr. Fatima Baltazar

  148. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

    Article • The Journal of Pathology, January 2006, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  149. Functional expression of the lactate permease Jen1p of Saccharomyces cerevisiae in Pichia pastoris

    Article • Biochemical Journal, December 2003, Portland Press Ltd.

    Dr. Fatima Baltazar

  150. l–[U–14C]Lactate binding to a 43 kDa protein in plasma membranes of Candida utilis

    Article • Microbiology, March 2000, Society for General Microbiology

    Dr. Fatima Baltazar